Literature DB >> 29946870

Comment on van Rongen et al., "Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults".

David M Reith1, Hesham Saleh Al-Sallami2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29946870     DOI： 10.1007/s40262-018-0691-0

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  4 in total

1.  Population pharmacokinetics of midazolam and its metabolites in overweight and obese adolescents.

Authors:  Anne van Rongen; Janelle D Vaughns; Ganesh S Moorthy; Jeffrey S Barrett; Catherijne A J Knibbe; Johannes N van den Anker
Journal:  Br J Clin Pharmacol       Date:  2015-09-10       Impact factor: 4.335

2.  Midazolam pharmacokinetics in morbidly obese patients following semi-simultaneous oral and intravenous administration: a comparison with healthy volunteers.

Authors:  Margreke J E Brill; Anne van Rongen; Aletta P I Houwink; Jacobus Burggraaf; Bert van Ramshorst; René J Wiezer; Eric P A van Dongen; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

3.  Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults.

Authors:  Anne van Rongen; Margreke J E Brill; Janelle D Vaughns; Pyry A J Välitalo; Eric P A van Dongen; Bert van Ramshorst; Jeffrey S Barrett; Johannes N van den Anker; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2018-05       Impact factor: 6.447

4.  Changes in duration of action of rocuronium following decrease in hepatic blood flow during pneumoperitoneum for laparoscopic gynaecological surgery.

Authors:  Yang Liu; Wen Cao; Yu Liu; Yun Wang; Ren Lang; Yun Yue; An-Shi Wu
Journal:  BMC Anesthesiol       Date:  2017-03-20       Impact factor: 2.217
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.